TrialPath

Find a study

Browse recruiting studies near you — free to check, always your choice.

Match me to a study

266 studies

Recruiting now, in plain language. Every study is watched over by an independent ethics board.

ListMap
Weight & metabolicPeptide & GLP-1Mental healthLungs & breathingHeart & circulationKidneyBrain & memoryBlood disordersImmune & autoimmuneSkin

134 studies on the map

Molecular Signatures of Cutaneous Dupilumab Response — University of California, San Francisco, San FranciscoEffectiveness of the Diabetes Homeless Medication Support (D-HOMES) Program on Diabetes Management — Hennepin Healthcare Research Institute, MinneapolisA Study of How Safe Abrocitinib (CIBINQO) is in Pregnant Women and Their Offspring — Pfizer, New YorkCircadian Intervention to Improve Cardiometabolic Health — College of Health Research Complex--University of Utah, Salt Lake CityAcute Exercise and Endogenous Glucose Production in Type 2 Diabetes: Implications for Glycemic Control and Treatment of Hepatic Steatosis — AdventHealth Translational Research Institute, OrlandoPilot of Continuous Glucose Monitor-Augmented Food Is Medicine — University of North Carolina at Chapel Hill, Chapel HillHealth Without Barriers/Salud Sin Barreras- Northern Colorado — Colorado State University, Fort CollinsOutcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus — Arizona Kidney Disease and Hypertension Center, PhoenixUsing Continuous Glucose Monitoring to Quantify the Effects of NOURISH's Culturally Modified Meals on Asian Americans With Type 2 Diabetes — Stanford University, StanfordThe CARING Study: Creating and Restoring Health Through Nutrition Guidance — Physicians Committee for Responsible Medicine, Washington D.C.Novel Digital Patient-Reported Outcomes Tool for Diabetes Management — NYU Langone Health, New YorkA Study to Learn About Study Medicine Called PF-08049820 in People With Eczema — Northridge Clinical Trials, NorthridgeLiver Transplant CGM — Mount Sinai Hospital, New YorkGLUCOSE-MGH: Genetic Links Understood Through Challenge With Oral Semaglutide Exposure at MGH — Massachusetts General Hospital, BostonUnderstanding Metabolism and Inflammation Risks for Diabetes in Adolescents — University of Michigan, Ann ArborA Study to Evaluate the Effect of Obicetrapib/Ezetimibe 10 mg Fixed-Dose Combination or Obicetrapib 10 mg Daily on Top of Guideline-Recommended Lipid-Lowering Therapy in Participants With Type 2 Diabetes and/or Metabolic Syndrome — Clinical Research Institute of Arizona, Sun City WestEffects of Ketone Ester Consumption on Exercise Tolerance and Cardiac Function — The Ross Heart Hospital, ColumbusEvaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis — National Institutes of Health Clinical Center, BethesdaKetogenic Diet and Diabetes Demonstration Project — University of New Mexico, AlbuquerqueMetabolic Profiling of Immune Responses in Immune-mediated Diseases — National Institutes of Health Clinical Center, BethesdaCardamom and Topical Roseomonas in Atopic Dermatitis — National Institutes of Health Clinical Center, BethesdaTrial Against INtractable Type 2 Diabetes (CAPTAIN-T2D) — Arizona Clinical Trials - Pecos, ChandlerAssessing the Efficacy of Targeted Home Visits in the Management of Chronic Conditions — UT Southwestern Medical Center, DallasMobile App Logging for Diabetes in Pregnancy — Augusta University, AugustaRegistry for Systemic Eczema Treatments — Johns Hopkins University, BaltimoreDietary Insights and Nutrition Experiences in Adults on GLP-1 Therapy - A Study on Diet Quality Changes in Adults on GLP-1 Therapy — University South Carolina, ColumbiaACT Intervention for Type 2 Diabetes Management for Rural and Underserved Community — Sam Houston State University College of Osteopathic Medicine, ConroePolypill for Prevention of Cardiomyopathy — UT Southwestern Medical Center, DallasYouth-Onset Type 2 Diabetes and Heart Disease: The Young at Heart Prospective Cohort Study — Children's National Hospital (CNH), Washington D.C.A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes — Lakeview Clinical Research, GuntersvilleA Biorepository of Multiple Allergic Diseases (MADREP) With Longitudinal Follow-Up — National Institutes of Health Clinical Center, BethesdaWild Blueberries for Gut, Brain, and Heart Health in Adults With High Blood Pressure — Georgia State University, AtlantaCulturally Tailored Program for Food-Insecure Adults: SPICE-D — Wake Forest University Health Sciences, Winston-SalemA Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS) — University of Arizona, TucsonDiabetes Management Using Continuous Glucose Monitors and Remote Patient Monitoring in Underserved Populations — Community Health Center of Franklin County, GreenfieldReal-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults — Galderma Investigational Site - 8893, BirminghamA Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D) — CenExel Anaheim Clinical Trials, AnaheimA Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis — Investigational Site, Fountain ValleyType 2 Continuous Glucose Monitoring Academy — Children's Hospital Los Angeles, Los AngelesA Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema — Cahaba Dermatology & Skin Health Center, LLC, BirminghamPharmacist-led Continuous Glucose Monitoring — USF Health Department of Family Medicine, TampaA Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD) — First OC Dermatology, IrvineSGLT2i, Ketoacidosis, Volume Contraction, and Insulinopenia — Texas Diabetes Institute/UH, San AntonioEvaluate Use of Tropocells(R) Autologous Platelet-rich Fibrin (PRF) for Wagner Grade 1 and Grade 2, Mild to Mod Neuroischemic Plantar Diabetic Foot Ulcer Wound Care. — WoundCentrics Wound Care & Hyperbarics -Corpus Christi - Shoreline, Corpus ChristiVirtual Diabetes Care for Adults With Type 2 Diabetes on Medicaid and Insulin Therapy — Rutgers Health Family Medicine at Monument Square, New BrunswickAcute and Chronic Effects of Oral Ketones in Subjects With HFrEF and Diabetes — University of Texas Health Science Center at San Antonio, San AntonioDupilumab De-escalation in Pediatric Atopic Dermatitis — Johns Hopkins Univerisity, BaltimorePrecision Dosing of Metformin in Youth With T2D — UCSF Benioff Children's Hospital Oakland, Pediatric Diabetes Clinic, OaklandNatural History and Genetics of Food Allergy and Related Conditions — National Institutes of Health Clinical Center, BethesdaA Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis — Mountain West Derm - Blackhart PLLC dba Skin Cancer and Dermatology Institute, PhoenixA Multicenter, Prospective, Controlled Clinical Trial Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers — Royal Research, HollywoodEffect of Sleep Extension on Ceramides in People with Overweight and Obesity — College of Health Research Complex--University of Utah, Salt Lake CityStudy to Compare Maternal, Fetal, and Infant Outcomes of Women With Mild to Moderate Atopic Dermatitis Exposed to Ruxolitinib Cream During Pregnancy With an Unexposed Control Population — Syneos Health (remote site), MorrisvilleSafety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes — University of Alabama, BirminghamEfficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus — Lynn Institute of the Ozarks, Little RockThe Role of Type 2 Diabetes on Skeletal Muscle Atrophy and Recovery Following Bed Rest in Older Adults — Translational Research Institute for Metabolism and Diabetes, OrlandoJoint Patient and Caregiver Intervention for Older African Americans With Type 2 Diabetes — Medical College of Wisconsin, MilwaukeeA Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus — Central Research Associates - Flourish - PPDS, BirminghamMechanism of SGLT2 Inhibition in the Kidney — University of Michigan, Ann ArborImplementing an Effective Diabetes Intervention Among Low-Income Immigrants — NYU Langone Health, New YorkHigh Fructose Diet, the Gut Microbiome, and Metabolic Health — Mount Sinai Morningside, New YorkHP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes — Alliance Clinical Canoga Park (Hope Clinical Research), Canoga ParkA Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis — Inmagene Site 1, LancasterPreventing Type 2 Diabetes in Black Emergent Adult — UNC-Chapel Hill, Chapel HillStudy to Evaluate Soquelitinib in Participants With Moderate to Severe AD — Corvus Clinical Trials, South San FranciscoFlourish: Exploring the Early Infant Gut Microbiome — Seeding Labs INC, AustinPh 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234 — Clinical Site 101, Fair LawnA Study to Evaluate ALN-4324 on Insulin Sensitivity in Adults With Type 2 Diabetes Mellitus — Clinical Trial Site, Chula VistaIH, Brain Health, and T2D — University of Iowa, Iowa CityTreatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down Syndrome — Icahn School of Medicine at Mount Sinai, New YorkA Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis — Hamilton Research, LLC, AlpharettaNYSCF Scientific Discovery Biobank — New York Stem Cell Foundation Research Institute, New YorkAchieving Routine Intervention and Screening for Emotional Health — University of Chicago, ChicagoSodium in the Skin and Atopic Dermatitis — San Francisco VA Medical Center, San FranciscoLebrikizumab in Moderate-to-severe Atopic Dermatitis — Physioseq USA - CA, FolsomImplementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2) — University of Alabama, BirminghamPhase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Who Are Not Achieving Glycemic Targets — Central Research Associates, LLC dba Flourish Research, BirminghamBrain Health in Youth With Normal Weight, Overweight and Obesity at Risk for Type 2 Diabetes (T2D) — Washington University School of Medicine, St LouisPreventing T2DM After GDM With Immediate Postpartum Screening — University of Massachusetts Memorial Medical Center, WorcesterPhase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy — Central Research Associates, LLC dba Flourish Research, BirminghamGlycemic Excursion Minimization (GEM) to Outshine Health Disparities — Georgia Prevention Institute, AugustaCorEvitas International Adolescent Atopic Dermatitis (AD) Drug Safety and Effectiveness Registry — CorEvitas, LLC, WalthamA Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis — Applied Research Center Of Arkansas /ID# 268547, Little RockExercise and Intranasal Insulin in Type 2 Diabetes — Robert Wood Johnson University Hospital Clinical Research Center, New BrunswickThe Treatment of Painful Diabetic Neuropathy With Diet — AdventHealth Hendersonville, HendersonvilleEnhancing Preventative Health Behaviors Among Emergency Department Hyperglycemic Patients — One Robert Wood Johnson Place, New BrunswickTopical Treatment for Atopic Dermatitis — Wake Forest University Health Sciences, Winston-SalemGlycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes — University Health - Texas Diabetic Institute, San AntonioImplementation of Team Clinic for Type 2 Diabetes (TCT2) — Children's Hospital Los Angeles, Los AngelesComparative Effectiveness of Two Initial Combination Therapies in Patients With Recent Onset Diabetes — University Health System Texas Diabetic Institute, San AntonioSubclinical Primary Aldosteronism in Diabetes At-Risk for Kidney Disease — Brigham and Women's Hospital, BostonDietary Insights and Nutritional Education in Adults on GLP-1 Therapy — University South Carolina, ColumbiaBalance4Mobility: Effects of Walkasins Use in Individuals With Peripheral Neuropathy and Balance Problems — OrthoArizona--Mesa Arbor Avenue, MesaThe Impact of Botox on Neuroimmune Interactions in Atopic Dermatitis — University of Pittsburgh Medical Center, PittsburghEvaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes — Sansum Diabetes Research Institute, Santa BarbaraEthnic Differences in Mechanisms of Action of Dupilumab — University of Michigan, Ann ArborStudy to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus — Lenzmeier Family Medicine, GlendaleContinuous Glucose Monitor Use in Pregnancy — University of Massachusetts Memorial Medical Center, WorcesterA Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis — AllerVie Clinical Research, BirminghamUsing Virtual Reality to Improve Medical Training — Ohio University, AthensSafety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis — Red River Research Partners, FargoEnhancing Diabetes Care: Exposome &Amp; Sensors — University of Illinois - Chicago, ChicagoExtracellular Vesicles, Insulin Action, and Exercise — Institute for Food, Nutrition, and Health, New BrunswickPrimary Care Pragmatic, Real World Experience for Automated Insulin Delivery — University of Colorado Anschutz Medical Campus, AuroraPATHS-UP Health Behavior Self-monitoring Mobile App for Adolescents — Children's Nutrition Research Center, HoustonThe Effect of Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in People With Type 1 and Type 2 Diabetes — Mayo Clinic in Rochester, RochesterDigital Health Navigation for Latino Patients With Type II Diabetes — Brigham and Women's Hospital, BostonA Low-Carb Approach to Treat Type 2 Diabetes in Pediatric Patients — University of Alabama at Birmingham/ Children's of Alabama, BirminghamFIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients — Anaheim Clinical Trials, LLC, AnaheimA Phase 1, Multiple Ascending Dose Study to Evaluate HMS1005 in Participants With Type 2 Diabetes — Clinical Pharmacology of Miami, MiamiFamilies Implementing Good Health Traditions for Life — Morehouse School of Medicine, AlbanyWearable Sensory Prosthesis to Improve Coordination, Walking, and Physical Activity — Brooks Rehabilitation Center, JacksonvilleDeveloping and Testing a Self-Compassion Tool Kit to Improve the Care of Individuals With Type 2 Diabetes — University of California, San Diego, San DiegoRole of KATP Channel Loss in Type 2 Diabetes — Washington University in St. Louis, St LouisContinuous Glucose Monitoring for Self-Management of Type 2 Diabetes in Young Adults — Scripps Health, San DiegoA 3-part Study of SYX-5219 in Healthy Volunteers and Participants With Atopic Dermatitis — Sitryx Clinical Site, Arkansas CityFood and Fitness With Medicine (FFWM) — Ohio State Healthy Community Center, ColumbusRole of Autophagy in Type 2 Diabetes Microvascular Dysfunction — Medical College of Wisconsin, MilwaukeeA Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight — Uni of Alabama at Birmingham, BirminghamSGLT2i, Pioglitazone, and Ketone Production in T2D — Texas Diabetes Institute/UH, San AntonioMichigan Food and Atopic Dermatitis (M-FAD) Program - Molecular Analytics Project — University of Michigan, Ann ArborPatient Centered Multi-Agent Decision Support System (PCM-DSS) for Healthcare Providers — University of Virginia Center for Diabetes Technology, CharlottesvilleModified Platform Trial Evaluating PpLHACM and SOC Versus SOC Alone in the Treatment of Nonhealing DFUs — SerenaGroup - Monroeville, MonroevilleImproving Appetite Self-Regulation in African American Adults With Type 2 Diabetes — Rachel W. Goode, KannapolisIntegrating Free-choice Marketplace, dieTitian coacHing, cultuRally Tailored messagIng to improVE Blood Pressure — Johns Hopkins Community Physicians, BaltimoreStudy to Evaluate if Exposure to Drug is Impacted in Participants With Renal Insufficiency — Syneos Miami, MiamiEfficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System — University of Southern California, Los AngelesRandomized Evaluation of Nonhealing Diabetic Foot Ulcers With Exclusive Wound Therapy — Serena Group- Monroeville, MonroevilleA Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis — Leo Pharma Investigational site, BirminghamTargeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2) — University of California, San Diego: Dermatology Clinical Trials Unit, San DiegoLINK-IT: Leveraging vIdeos and commuNity Health worKers to Improve Diabetes OuTcomes — NYU Langone Health, New YorkA Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis — AllerVie Clinical Research, BirminghamSafety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes — SUNY Upstate Medical Center, AlbanyNon-interventional Pre-screening Protocol Aims to Evaluate Participants for Potential Trial Eligibility in Future Clinical Trials/Studies Focusing on Metabolic and Psychiatric Health. — Clindove Research LLC, Brooklyn

Showing the 150 nearest — narrow your filters for fewer, closer studies.